Photodiagnosis and photodynamic therapy · 2026
Phenalenone-Based Photosensitizers for Antimicrobial Photodynamic Inactivation of Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hu Xingmei, Jin Xiaohan, Tian Chunbao, Chen Mei, Chen Wenjing, Li Xin, Xu Peng, Zhao Lijuan, Xu Yiren, Ma Wenhui, Li Xueling, Zhang Jianqiang
Аннотация
BACKGROUND AND OBJECTIVE: Antimicrobial photodynamic therapy (aPDT) relies on activation of a photosensitizer by light in the presence of oxygen, leading to reactive oxygen species formation. Here, a phenalenone derivative series was examined to find green-light-responsive compounds for photodynamic inactivation of methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA).
METHODS: Twelve phenalenone derivatives were first compared for visible absorption, photostability, macroscopic appearance in the assay medium, and relative singlet-oxygen generation using ABDA bleaching. Based on this screen, compounds 4d and 4m were taken forward for microbiological testing. Bacterial association, viable counts, residual metabolic activity, and intracellular ROS-related fluorescence were assessed by confocal microscopy, CFU enumeration, resazurin reduction, and DCFDA fluorescence, respectively. All microbiological efficacy experiments were performed with planktonic bacterial suspensions; biofilm activity was not evaluated in the present study.
RESULTS: All derivatives absorbed within 512.5-571.0 nm and retained 0.977-0.989 of their initial absorbance after 3 h of green-light irradiation. The ABDA-derived apparent ΦΔ estimates were 0.25-0.60. Compound 4d had the highest apparent ΦΔ estimate, showed no visible precipitation at 16 μM under the working conditions, and gave the most pronounced antibacterial response under 530-540 nm irradiation. Compound 4m showed similar photophysical behavior but left higher residual survival under lower-dose conditions. For both compounds, irradiation increased ROS-associated fluorescence and reduced viable counts and resazurin signals in a concentration- and fluence-dependent manner.
CONCLUSIONS: Within this series, 4d gave the most favorable profile, combining the highest ABDA-derived apparent ΦΔ estimate, absence of visible precipitation at the screening concentration, and strong green-light-triggered activity against both MSSA and MRSA. Because the ABDA result was not validated by an orthogonal singlet-oxygen method, it is interpreted as a comparative screening estimate rather than a definitive absolute ΦΔ measurement. The present visual screen does not establish molecular aggregation state; further evaluation should prioritize quantitative aggregation/solubility measurements, biofilm experiments, formulation development, and mammalian-cell compatibility. Mammalian-cell cytotoxicity was not measured in the present study, so a therapeutic selectivity index cannot yet be calculated.
METHODS: Twelve phenalenone derivatives were first compared for visible absorption, photostability, macroscopic appearance in the assay medium, and relative singlet-oxygen generation using ABDA bleaching. Based on this screen, compounds 4d and 4m were taken forward for microbiological testing. Bacterial association, viable counts, residual metabolic activity, and intracellular ROS-related fluorescence were assessed by confocal microscopy, CFU enumeration, resazurin reduction, and DCFDA fluorescence, respectively. All microbiological efficacy experiments were performed with planktonic bacterial suspensions; biofilm activity was not evaluated in the present study.
RESULTS: All derivatives absorbed within 512.5-571.0 nm and retained 0.977-0.989 of their initial absorbance after 3 h of green-light irradiation. The ABDA-derived apparent ΦΔ estimates were 0.25-0.60. Compound 4d had the highest apparent ΦΔ estimate, showed no visible precipitation at 16 μM under the working conditions, and gave the most pronounced antibacterial response under 530-540 nm irradiation. Compound 4m showed similar photophysical behavior but left higher residual survival under lower-dose conditions. For both compounds, irradiation increased ROS-associated fluorescence and reduced viable counts and resazurin signals in a concentration- and fluence-dependent manner.
CONCLUSIONS: Within this series, 4d gave the most favorable profile, combining the highest ABDA-derived apparent ΦΔ estimate, absence of visible precipitation at the screening concentration, and strong green-light-triggered activity against both MSSA and MRSA. Because the ABDA result was not validated by an orthogonal singlet-oxygen method, it is interpreted as a comparative screening estimate rather than a definitive absolute ΦΔ measurement. The present visual screen does not establish molecular aggregation state; further evaluation should prioritize quantitative aggregation/solubility measurements, biofilm experiments, formulation development, and mammalian-cell compatibility. Mammalian-cell cytotoxicity was not measured in the present study, so a therapeutic selectivity index cannot yet be calculated.